Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 94 citing Baggio: A recombinant human glucagon-like peptide (GLP)-1–albumin protein (albugon) mimics.... (0.09 sec) 

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 …


DJ Drucker, MA Nauck - The Lancet, 2006 - Elsevier
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that
stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying,
and reduces appetite and food intake. Therapeutic approaches for enhancing ...
Cited by 408 - Related articles - All 10 versions

Biology of incretins: GLP-1 and GIP

- rh.dk [PDF] 
LL Baggio, DJ Drucker - Gastroenterology, 2007 - Elsevier
This review focuses on the mechanisms regulating the synthesis, secretion,
biological actions, and therapeutic relevance of the incretin peptides
glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Cited by 173 - Related articles - All 25 versions

Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through …

- endojournals.org
T Talsania, Y Anini, S Siu, DJ Drucker, PL … - Endocrinology, 2005 - Endocrine Soc
Glucagon-like peptide-1 7–36NH2 (GLP-1) and peptide YY 3–36NH2 (PYY
3–36NH2 ) are cosecreted from the intestine in response to nutrient ingestion.
Peripheral administration of GLP-1 or PYY 3–36NH2 decreases food intake ...
Cited by 86 - Related articles - BL Direct - All 6 versions

Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1

- glucagon.com [PDF]  - Free from Publisher
MC Riddle, DJ Drucker - Diabetes Care, 2006 - Am Diabetes Assoc
Current therapies for type 2 diabetes are frequently associated with inadequate
control of postprandial hyperglycemia, weight gain, and, in the case of oral
agents, loss of efficacy over time. A better understanding of physiological ...
Cited by 71 - Related articles - BL Direct - All 10 versions

[PDF] Biologic actions and therapeutic potential of the proglucagon-derived peptides


DJ Drucker - Nature Clinical Practice Endocrinology and Metabolism, 2005 - glucagon.com
INTRODUCTION Before the cDNAs and genes encoding pro glucagon were cloned,
pancreatic glucagon was the prin- cipal proglucagon-derived peptide (PGDP) with
well-characterized biologic actions. However, antisera directed against ...
Cited by 59 - Related articles - View as HTML - BL Direct - All 6 versions

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left …

- physiology.org
LA Nikolaidis, D Elahi, YT Shen, RP Shannon - American Journal of Physiology- Heart and Circulatory …, 2005 - Am Physiological Soc
We have shown previously that the glucagon-like peptide-1 (GLP-1)-(7–36) amide
increases myocardial glucose uptake and improves left ventricular (LV) and
systemic hemodynamics in both conscious dogs with pacing-induced dilated ...
Cited by 39 - Related articles - BL Direct - All 5 versions

Proglucagon-derived peptides: mechanisms of action and therapeutic potential

- physiology.org
EM Sinclair, DJ Drucker - Physiology, 2005 - Am Physiological Soc
The proglucagon-derived peptides (PGDPs) are encoded by a single mammalian
proglucagon gene. Tissue-specific posttranslational processing mediated by
prohormone convertase (PC) enzymes liberates these peptide hormones in a ...
Cited by 29 - Related articles - All 4 versions

Therapeutic peptides: technological advances driving peptides into development


AK Sato, M Viswanathan, RB Kent, CR Wood - Current opinion in biotechnology, 2006 - Elsevier
As potential therapeutics, peptides offer several advantages over small
molecules (increased specificity) and antibodies (small size). Nevertheless, a
number of key issues have hampered their use as drug candidates. A series ...
Cited by 27 - Related articles - All 5 versions

Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C


GM Subramanian, M Fiscella, A Lamousé- … - Nature biotechnology, 2007 - nature.com
Treatment regimens based on the use of interferon- (IFN- ) remain the
cornerstone of therapy for chronic hepatitis C virus infection, which affects
nearly 170 million people worldwide. Treatment options include unmodified ...
Cited by 25 - Related articles - BL Direct - All 4 versions

Incretin hormone mimetics and analogues in diabetes therapeutics

- qub.ac.uk [PDF] 
BD Green, PR Flatt - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier
The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent
insulinotropic polypeptide (GIP) are physiological gut peptides with
insulin-releasing and extrapancreatic glucoregulatory actions. Incretin ...
Cited by 29 - Related articles - All 17 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google